title: Congenital adrenal hyperplasia and pregnancy.
abstract: A 32-year-old woman with classical congenital adrenal hyperplasia (CAH) secondary to 21-hydroxylase deficiency presented with infertility. She was treated with different steroid replacement regimens together with fludrocortisone. The aim of this case report is to discuss fertility barriers in women with classical CAH, and emphasise the risks and benefits of available steroid treatment options. Clinical considerations covered include preconception health and fertility planning, optimising fertility through suppression of excess hormone production, reducing fetal androgen exposure in utero and limiting maternal and fetal side effects of therapy and limiting chances of CAH in the baby. In this case suppression of androgen and progesterone levels was challenging but eventually was achieved and resulted in a spontaneous pregnancy. However, she miscarried in the first trimester, and fetal biopsy revealed a complete hydatiform mole. She is advised not to conceive while she is under investigation to determine the extent of the disease.
authors.affiliation: Monash Health, Clayton, Victoria, Australia. solshoraka@yahoo.com
authors.forename: Soulmaz
authors.initials: S
authors.lastname: Shorakae
authors.forename: Helena
authors.initials: H
authors.lastname: Teede
mesh_terms: D000022:Abortion, Spontaneous / Q000209:etiology; D000312:Adrenal Hyperplasia, Congenital / Q000150:complications; D000328:Adult; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications
references.citation: Clin Endocrinol (Oxf). 2001 Oct;55(4):523-9
references.pmid: 11678836
references.citation: Clin Endocrinol (Oxf). 2009 Jun;70(6):833-7
references.pmid: 19250265
references.citation: BJOG. 2003 Jun;110(6):555-9
references.pmid: 12798471
references.citation: Eur J Endocrinol. 2006 Mar;154(3):405-8
references.pmid: 16498053
references.citation: Lancet Oncol. 2003 Nov;4(11):670-8
references.pmid: 14602247
references.citation: Horm Res Paediatr. 2011;76(2):73-85
references.pmid: 21597280
references.citation: Fertil Steril. 2003 Oct;80(4):1030-6
references.pmid: 14556829
references.citation: N Engl J Med. 1987 Jan 22;316(4):178-82
references.pmid: 3491959
references.citation: Eur J Endocrinol. 2012 Oct;167(4):499-505
references.pmid: 22893695
references.citation: J Clin Endocrinol Metab. 2012 Oct;97(10):E1890-7
references.pmid: 22802086
references.citation: Hum Reprod. 2008 Jul;23(7):1607-13
references.pmid: 18420648
references.citation: J Clin Endocrinol Metab. 2010 Sep;95(9):4133-60
references.pmid: 20823466
references.citation: J Clin Endocrinol Metab. 2010 Nov;95(11):5110-21
references.pmid: 20719839
references.citation: J Clin Endocrinol Metab. 2007 Apr;92(4):1391-6
references.pmid: 17284631
references.citation: Clin Obstet Gynecol. 2003 Sep;46(3):541-56
references.pmid: 12972736
references.citation: Acta Obstet Gynecol Scand. 2000 Aug;79(8):687-92
references.pmid: 10949235
references.citation: Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):489-96
references.pmid: 23108200
references.citation: Obstet Gynecol Surv. 2003 Apr;58(4):275-84
references.pmid: 12665708